Advanced Approaches to Anti-aging −Use of Aging Model Animals− |
| A. Ishigami and H. Manya |
| J. Pharm. Soc. Jpn., 130(1),1-2, 2010 |
|
Antiaging Research Using Klotho Mice |
| H. Manya, K. Akasaka-Manya, and T. Endo |
| J. Pharm. Soc. Jpn., 130(1),3-9, 2010 |
|
Anti-aging Studies on the Senescence Accelerated Mouse (SAM) Strains |
| R. Takahashi |
| J. Pharm. Soc. Jpn., 130(1),11-18, 2010 |
|
Anti-aging Research Using Mn-SOD Conditional Knockout Mice |
| T. Shimizu and T. Shirasawa |
| J. Pharm. Soc. Jpn., 130(1),19-24, 2010 |
|
Anti-aging Research Using SMP30/GNL Knockout Mice |
| A. Ishigami |
| J. Pharm. Soc. Jpn., 130(1),25-28, 2010 |
|
Analysis of Aging-related Oxidative Stress Status in Normal Aging Animals and Development of Anti-aging Interventions |
| T. Sasaki |
| J. Pharm. Soc. Jpn., 130(1),29-42, 2010 |
|
Development of a Technology Platform for Novel Drug Discovery Aimed at Regulating Biological Function |
| T. Nomura, H. Kayamuro, and S. Tsunoda |
| J. Pharm. Soc. Jpn., 130(1),43-44, 2010 |
|
Artificial Transcription Factors Based on Multi-zinc Finger Motifs |
| T. Morisaki, M. Imanishi, S. Futaki, and Y. Sugiura |
| J. Pharm. Soc. Jpn., 130(1),45-48, 2010 |
|
Enhancement of Antibody-dependent Cellular Cytotoxicity by Tandem Fc Multimerization |
| H. Nagashima and Y. Masuho |
| J. Pharm. Soc. Jpn., 130(1),49-54, 2010 |
|
Application of Bioactive Mutant TNF Alpha to a Mucosal Vaccine Adjuvant |
| H. Kayamuro, Y. Yoshioka, Y. Abe, H. Kamada, S. Tsunoda, and Y. Tsutsumi |
| J. Pharm. Soc. Jpn., 130(1),55-61, 2010 |
|
Creation of TNFR1-selective Antagonist and Its Therapeutic Effects |
| T. Nomura, Y. Abe, Y. Yoshioka, S. Nakagawa, S. Tsunoda, and Y. Tsutsumi |
| J. Pharm. Soc. Jpn., 130(1),63-68, 2010 |
|
Correlation of Pharmacokinetic Parameters with Serum Vancomycin Concentration in Elderly Patients with Malignancies |
| S. Sadoh, Y. Tsuji, and K. Tsukamoto |
| J. Pharm. Soc. Jpn., 130(1),69-73, 2010 |
|
Preparation of Orally Disintegrating Tablets with Masking of Unpleasant Taste: Comparison with Corrective-adding Methods |
| Y. Kawano, A. Ito, M. Sasatsu, and Y. Machida |
| J. Pharm. Soc. Jpn., 130(1),75-80, 2010 |
|
Preparation of Orally Disintegrating Tablets with Taste-masking Function: Masking Effect in Granules Prepared with Correctives Using the Dry Granulation Method and Evaluation of Tablets Prepared Using the Taste-masked Granules |
| Y. Kawano, A. Ito, M. Sasatsu, and Y. Machida |
| J. Pharm. Soc. Jpn., 130(1),81-86, 2010 |
|
Doripenem Pharmacokinetics in Critically Ill Patients Receiving Continuous Hemodiafiltration (CHDF) |
| S. Hidaka, K. Goto, S. Hagiwara, H. Iwasaka, and T. Noguchi |
| J. Pharm. Soc. Jpn., 130(1),87-94, 2010 |
|
Prediction of Incompatibility of Ceftriaxone Sodium with Calcium Ions Using the Ionic Product |
| Y. Nakai, E. Tokuyama, M. Yoshida, and T. Uchida |
| J. Pharm. Soc. Jpn., 130(1),95-102, 2010 |
|
Preparation of PLGA Microspheres Encapsulating Highly Concentrated Glycyrrhizin and the Bile Elimination of Glycyrrhizin after Subcutaneous Administration in Rats |
| K. Ohyanagi, K. Shintani, and K. Koga |
| J. Pharm. Soc. Jpn., 130(1),103-111, 2010 |
|
Pharmacokinetics of Orally Administered Tacrolimus in Lupus Nephritis Patients |
| K. Uchida, Y. Asamiya, T. Takei, M. Itabashi, H. Sugiura, M. Tsukada, and K. Nitta |
| J. Pharm. Soc. Jpn., 130(1),113-118, 2010 |
|
Development of Semisolid Dosage Form of Clonazepam for Oral Cavity Administration |
| O. Sakata, H. Onishi, and Y. Machida |
| J. Pharm. Soc. Jpn., 130(1),119-125, 2010 |
|
Pharmacological Assessment of ARTCEREB® Irrigation and Perfusion Solution for Cerebrospinal Surgery Based on Glucose Incorporation Activity in Primary Cultures of Rat Brain Cells |
| M. Nishimura, K. Doi, and S. Naito |
| J. Pharm. Soc. Jpn., 130(1),127-130, 2010 |
|
Collecting and Sharing Information about Dietary Supplements and Functional Foods among Healthcare Professionals Using Internet-based System |
| Y. Asahina, S. Hori, and Y. Sawada |
| J. Pharm. Soc. Jpn., 130(1),131-139, 2010 |